baber/WOPTO huggingface dataset:
Patent AU-3439202-A (AU)
Title: A device for supplying feed to animals
Inventor: LELY ALEXANDER VAN DER
IPC: A01K5/02
Filed: 2002-04-18
Abstract: A device for supplying feed to animals, such as cows. The device is provided with a feeding trough (6) which is accessible to an animal, with a bottom (5) having a floor portion (8) on which an animal can stand, and with identification means (7) for identifying an individual animal. The distance between the feeding trough (6) and the floor portion (8) is adjustable. The distance between the feeding trough (6) and the floor portion (8) is automatically adjustable with the aid of data from the identification means (7). An assembly of a device for supplying feed to animals, such as cows, said device being provided with a feeding trough (6) which is accessible to an animal, and with identification means (7) for identifying an individual animal, and with a bottom (5) having a floor portion (8) on which an animal can stand for making use of the device, the distance between the feeding trough (6) and the floor portion (8) being adjustable. The floor portion (8) is provided with means (28) for adjusting the orientation of the floor portion (8) relative to the bottom (5), and with means for locking the floor portion (8) in an adjusted position. <IMAGE>
Patent AU-3564599-A (AU)
Title: Inhibition of xenoreactive antibodies
Inventor: SCHWARZ ALEXANDER
IPC: A61K47/48
Filed: 1999-04-15
Abstract: One aspect of the present invention relates to methods and compositions for attenuating xenograft rejection by administering, to an animal receiving the xenograft, an amount of a polymer-derivatized xenoantigen (hereinafter "xenopolymer") effective for inhibiting or lessening the severity of hyperacute rejection response (HAR), or other immunological response to the graft, that is dependent on the presence of the xenoantigen on the grafted tissues or cells. In certain embodiments, the xenopolymer is administered in an amount sufficient to neutralize host antibodies ("xenoreactive antibodies" or "XNA") immunoreactive with the xenoantigen. The xenopolymer may additionally, or alternatively, be used as a tolerogen (or anergen) for the xenoantigen, e.g., able to suppress, to some degree, the production/secretion of XNAs by the immune system of the host.
Patent AU-3591589-A (AU)
Title: Process for connection of supports, and support system
Inventor: TATSUO ONO
IPC: E04G7/18
Filed: 1989-05-31
Abstract: The support system is suitable for use in forming temporary scaffolding such as a prefabricated scaffolding, a temporary system such as a panel support, or a structure such as a truss-type pillar, tower, etc. The support system comprises columnar members (1) each provided with a plurality of flanges (11) along the longitudinal direction thereof, connecting members (2) each provided with joint shoes (21) at both ends thereof, and wedges (3) each driven into the joint shoe (21), the flanges (11) each comprising a supporting piece (11a) around the circumferential direction thereof, the joint shoes (21) each comprising a hollow housing (c) having a pair of opposed wall bodies (a,b) and a hook (22) loosely fitted movably in the housing, the wall bodies (a,b) and the hook (22) being provided with respective wedge insertion holes (21a,21b,22a) opposed to each other, and the hook (22) being provided at an end portion thereof with a catch portion (g) to be engaged with the supporting piece (11a) of the flange (11). When the wedge (3) is driven into the wedge insertion holes (21a,21b,22a) in the condition where the catch portion (g) is opposed to the supporting piece (11a), the hook (22) is retracted. This causes engagement of the catch portion (g) with the supporting piece (11a), and end portions (e) of the wall bodies (a,b) are pushed outwards into contact with the outer surface of the columnar member (1).
Patent AU-3680395-A (AU)
Title: Fascia vent
Inventor: ROTTER MARTIN J
IPC: E04D13/17
Filed: 1995-09-12
Abstract: A building structure adapted allows for ventilation of vapors from within the structure so as to retard deterioration of the structure. The building structure has a roof extending over one or more vertical side walls. An attic space is enclosed between the roof and an internal ceiling. The roof is constructed on a plurality of parallel rafters. The rafters are supported by a top plate capping each vertical side wall. The roof has a roof sheathing member overlying the roof rafters. A fascia is secured to the outer ends of the roof rafters and at least one portion of the fascia is spaced from the outer ends of the rafters. An air permeable and resilient strip is interposed between the fascia and the outer ends of the rafters to provide for the flow of vapor therebetween and into the attic.
Patent AU-3696895-A (AU)
Title: Target input for a navigation system
Inventor: WAIZMANN GERD
IPC: G01C21/34
Filed: 1995-10-05
Abstract: PCT No. PCT/DE95/01414 Sec. 371 Date Apr. 7, 1997 Sec. 102(e) Date Apr. 7, 1997 PCT Filed Oct. 5, 1995 PCT Pub. No. WO96/11380 PCT Pub. Date Apr. 18, 1996A process and a device for providing navigational assistance to a vehicle driver in reaching a target position in a vehicle, in which the current local position is identified, a route is determined and current travel tips for this route are obtained from a traffic computer, which is disposed outside of the vehicle, and are displayed to the driver. To provide fully automatic navigational assistance in which the driver's input is minimized, especially in the case of frequently repeated routine trips, the target position is derived automatically, according to probability, on the basis of stored historical travel information.
Patent AU-3705193-A (AU)
Title: Aqueous non-blocking tinter for paints and the like
Inventor: COUTTS JENNIFER RUTH
IPC: C09D17/00
Filed: 1993-04-21
Abstract: For paints and the like, an aqueous tinter which does not block dispensing nozzles and which has a viscosity of from 0.05 to 1.5 Ns/m<2> (20 DEG C) and which contains pigment particles, water, micellising dispersant and a non-micellising auxiliary material. The weight ratio of dispersant to pigment must exceed the ratio which would be present at the Daniel Flow Point for a notional tinter consisting only of the pigment, water and the dispersant. The amount of auxiliary material must be sufficient to enable the tinter to be expelled through a bore 2mm in diameter and 15mm long by a pressure of not more than 320 MN/m<2> after storage in the bore at 25 DEG C for 18 hours under a relative humidity of 50%. Preferred dispersants comprise long chain hydrophilic and long chain hydrophobic moieties which may be poly(alkylene glycol) esters of long chain fatty acids or hydrophobic backbone copolymers with pendant poly(alkylene glycol) moieties as hydrophilic side chains.
Patent AU-3736385-A (AU)
Title: (piperidine-4-yl-amino)-benzimidazoles/imida-20 pyrines
Inventor: JANSSENS FRANS EDUARD
IPC: C07D409/12
Filed: 1985-01-07
Abstract: Novel N-heterocyclyl-4-piperidinamines of formula 
<CHEM>
 wherein L is a radical of formula 
<CHEM>
 Het-Alk- (b-5); (lower alkenyl)-Y<1>-Alk- (b-6); or Ar-Alk- (b-7); the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are anti-allergic agents, pharmaceutical compositions containing such compounds as an active ingredient and processes for preparing the said compounds and compositions.
Patent AU-3943995-A (AU)
Title: Process for purifying factor viii
Inventor: ALMSTEDT ANNELIE
IPC: A61K38/00
Filed: 1995-11-14
Abstract: PCT No. PCT/SE95/01351 Sec. 371 Date May 30, 1997 Sec. 102(e) Date May 30, 1997 PCT Filed Nov. 14, 1995 PCT Pub. No. WO96/15150 PCT Pub. Date May 23, 1996A process for reducing degradation of recombinant coagulation factor VIII caused by metal-dependent proteases requiring Zn2+ for activity or containing Zn2+ as an integral part of their structure comprises adding an inhibitor of Zn2+ dependent proteases to a recombinant factor VIII solution. The recombinant factor VIII solution is obtained after harvesting a conditioned medium from a cell culture used for producing the recombinant coagulation factor VIII. The inhibitor is selected from complexing agents with a stronger affinity for the Zn2+ ion of the protease than for the ion or ions stabilizing the factor VIII molecule, and compounds structurally related to the natural substrate of the protease and containing an electronegative moiety.
Patent AU-3955400-A (AU)
Title: The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application
Inventor: SHAO YIMING
IPC: C07K14/155
Filed: 2000-04-21
Abstract: This invention discloses the full-length proviral genome DNA sequence of Donkey Leukocyte Attenuated Equine Infectious Anemia Virus Vaccine strain, nucleotide and amino acid sequences of all functional genes, and uses of each functional gene and its expression product. The vaccine strain involved in this invention was derived from an isolate in China. <IMAGE>
Patent AU-4054593-A (AU)
Title: Therapeutic compositions
Inventor: NAGLEY PHILLIP
IPC: A61K45/00
Filed: 1993-05-28
Abstract: PCT No. PCT/AU93/00251 Sec. 371 Date Mar. 20, 1995 Sec. 102(e) Date Mar. 20, 1995 PCT Filed May 28, 1993 PCT Pub. No. WO93/24650 PCT Pub. Date Dec. 9, 1993The present invention relates generally to therapeutic compositions comprising one or more redox compounds. The therapeutic compositions of the present invention are useful in enhancing cellular ATP production thereby ameliorating the effects of reduced bioenergy capacity such as occurring during aging, systemic or vascular disease or in conjunction with chemical therapy. The present invention therefore contemplates a method for enhancing cellular ATP production in an animal, said method comprising administering to said animal, an effective amount of a redox compound for a time and under conditions sufficient to increase or otherwise elevate the activity and/or operation of a cellular oxidoreductase system in cells of said animal.
Patent AU-4541200-A (AU)
Title: Silicon-based impression compounds with improved non-sag properties
Inventor: ZECH JOACHIM
IPC: A61K6/90
Filed: 2000-03-31
Abstract: The invention relates to silicone-based addition-crosslinking impression material, containing(a) organopolysiloxanes with at least two unsaturated groups in the molecule,(b) organohydrogen polysiloxanes with at least three Si-H groups in the molecule,(c) optionally, organopolysiloxanes without reactive groups,(d) platinum catalyst,(e) optionally, hydrophilizing agent,(f) filler,(g) optionally, further customary additives, auxiliaries and dyes,characterized in that it contains, as component (h), polyalkylene oxide and/or its derivatives with an average molar mass of Mw>1000 at the rate of 0.001 to 1.0 wt.-% relative to the total mass of the cured material.
Patent AU-4557097-A (AU)
Title: Oral delayed immediate release formulation and method of preparation therefor
Inventor: ELBERS JULES ALEX CORNELIS
IPC: A61P11/06
Filed: 1997-09-18
Abstract: The invention relates to an Oral Delayed Immediate Release formulation comprising a compressed core containing one or more active substances surrounded with a coating, wherein release of active substance from the core is caused by rupture of the coating after a definite lag-time, said core comprising one or more immediate release carriers and having no substantial swelling properties upon exposure to gastrointestinal fluids. The invention further relates to formulations containing an Immediate Release formulation combined with one or more Oral Delayed Immediate Release formulations with different lag-times and to a method of preparing an Oral Delayed Immediate Release formulation.The Oral Delayed Immediate Release formulation may be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere compounds, anti-hypertensives, sedatives, anti-depressants, anti-anxiety compounds, cortico-steroids, general anti-inflammatory compounds, anti-inflammatory compounds for gastrointestinal use, anti-ulceratives, analgetics, anti-aritmics, anti-rheumatics, anti-arthritic compounds and anti-angina compounds.The Oral Delayed Immediate Release formulation may also be used for the application of biological active compounds such as proteins, peptides, enzymes, vaccines and oligonucleotides.
Patent AU-4579485-A (AU)
Title: Injection solution
Inventor: LOEBEL KLAUS-DIETER
IPC: A61K31/52
Filed: 1985-08-02
Abstract: An aqueous injection solution contains 1-25% by weight of 2-hydroxy-N,N,N-trimethyl-ethanaminium salt of 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1) and, based on this salt, 5-8% by weight of propionic acid.
Patent AU-4622785-A (AU)
Title: Production of carboxylic anhydrides from methyl carboxylates using rhodium complex catalysts
Inventor: WEGMAN RICHARD WILLIAM
IPC: C07C51/56
Filed: 1985-08-15
Abstract: @ A process for the production of organic carboxylic anhydrides by the catalytic reaction of a methyl carboxylate and carbon monoxide in contact with a homogeneous catalyst system of rhodium metal atom, a phosphorus-containing ligand in which there is present at least one oxo (=0) oxygen atom attached to a phosphorus atom or a carbon atom to form a Z group and thegroup in said Z group is located at least one carbon atom removed and preferably from 2-4 carbon atoms removed from the phosphorus atom of the molecules represented by the formulasorand a halogen source, under mild reaction conditions, wherein R' is aryl, alKaryl, aralkyl or alkyl, and wherein 1 or more of said R' groups can be substituted with a Z group but not more than 3 of said R' groups in the molecule are so substituted; a is an integer from 0-4; b is an integer from 0-3 and Z is P(O)R'R'; - C(O)OR" or C(O)R", wherein R" is R or -H.
Patent AU-4714201-A (AU)
Title: Supracolonic aerodigestive neoplasm detection
Inventor: SHUBER ANTHONY P
IPC: C12Q1/68
Filed: 2000-12-07
Abstract: The invention provides methods and materials for detecting supracolonic aerodigestive premalignant and malignant neoplasms. Specifically, the invention provides methods and materials for determining whether a stool sample from a mammal contains a neoplasm-specific marker from a neoplasm located in the supracolonic aerodigestive tissue of a mammal.
Patent AU-4734696-A (AU)
Title: Knitted garment panel
Inventor: NILSSON EIVOR
IPC: D04B1/24
Filed: 1996-02-13
Abstract: A knitted panel for producing a machine knitted garment of type waistcoat or jacket in one piece with a divided front. The main part of said panel or at least a strip section (19) adjacent one or more of the edges (11) of the panel is formed by knitting in double bed. An additional section (20) outermost along said edge (11) is formed by knitting in a single bed, wherein said outer section forms a rolled piping. The front is partly folded outward or inward, e.g. for forming a neck opening (21) and/or a pocket.
Patent AU-4756785-A (AU)
Title: Improved heart valve
Inventor: BOKROS JACK CHESTER
IPC: A61F2/24
Filed: 1985-09-18
Abstract: A heart valve prostheses (121) comprising a generally annular body (123) which has an interior surface (127) that defines a central passageway for blood flow therethrough, occluder means (125) supported on said body for alternately blocking and then allowing the flow of blood through said passageway in a predetermined direction, said occluder means (125) being formed with means at opposite locations in the periphery thereof that cooperate with complementary means interior of said annular body, and a pair of opposed seat means (161,163) provided on the interior surface (127) of an annular body (123), each of said seat means (161,163) having a surface which is generally that of a portion of a frustum of a cone so that when the periphery of the occluder (125) engages said pair of seat means (161,163) in the closed position a good seal is achieved therealong.
Patent AU-4765197-A (AU)
Title: Genetic mechanisms of tumor suppression
Inventor: LEE WEN-HWA
IPC: C07K14/47
Filed: 1997-12-09
Abstract: A method for utilizing p53 cDNA, and p53 gene products for the suppression of the neoplastic phenotype. <IMAGE>
Patent AU-4766099-A (AU)
Title: Disturbance-free electromyographic probe
Inventor: SINDERBY CHRISTER
IPC: A61B5/296
Filed: 1999-07-16
Abstract: A myographic probe for detecting an electrical signal produced by a muscle and for reducing the influence of electrode disturbances. The probe includes electrodes and a disturbance reducing interface covering each electrode thereby segragating the electrodes from the muscle. Electrode disturbances include problems such as those related to the motion of the electrodes, changes in the pressure applied to the electrode, and/or intermittent contact with sourrounding tissue. The disturbance reducing interface is ion permeable and is, when dry, less conductive than the electrodes. The disturbance reducing interface may comprise a matrix of permeable material such as a mesh, foam, or other porous materials. The probe may be in the form of a catheter and be advantageously used in a human cavity such as the oesophagus. Another advantage of the invention is the possibility of using electrodes which are different from conventional wound wire electrodes.
Patent AU-4769493-A (AU)
Title: Glial mitogenic factors, their preparation and use
Inventor: GOODEARL ANDREW DAVID JOHN
IPC: C12N15/19
Filed: 1993-06-29
Abstract: The invention relates to isolated nucleic acid molecules which encode for part or all of glial growth factor molecules, as well as recombinant vectors and transfected cell lines.
Patent AU-4851390-A (AU)
Title: Mesogenic epoxy compounds
Inventor: EARLS JIMMY D
IPC: C07D303/24
Filed: 1990-01-16
Abstract: Epoxy resins containing mesogenic or rodlike moieties are prepared from hydroxyl-containing compounds which contain such moieties.
Patent AU-5062499-A (AU)
Title: Dental pin
Inventor: SANTAR IVAN
IPC: A61K6/898
Filed: 1999-07-21
Abstract: A biocompatible intermolecular polymer complex comprises an anionic component and a non protein cationic component. The anionic component comprises a linear or branched polysaccharide chain wherein at least 5% of the basic structural units are glucuronic acid. The cationic component comprises a linear or branched natural, semi-synthetic or synthetic oligomer or polymer.
Patent AU-5160993-A (AU)
Title: Bifidobacterium growth promoter
Inventor: TOSHIHIKO ASANO
IPC: A23L27/30
Filed: 1993-10-14
Abstract: A bifidobacterium growth promoter containing gluconic acid, a nontoxic salt thereof and/or glucono- delta -lactone as the active ingredient. It has not only a selective bifidobacterium growth promoter effect but also the effect of inhibiting the growth of deleterious bacteria. Further, it is reduced in the rate of digestion and absorption in the upper alimentary tract and hence has excellent characteristics as a bifidus factor. Therefore, this promoter can be used per se or as an additive for various food and drink to provide functional food and drink, thus being remarkably useful from the viewpoint of health improvement.
Patent AU-5411598-A (AU)
Title: Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
Inventor: OHUCHIDA SHUICHI
IPC: C07D307/64
Filed: 1997-12-12
Abstract: The sulfonamide or carboamide derivatives of the formula (I) and a pharmaceutical composition which comprise them as an active ingredient: <CHEM> (wherein A ring, B ring is carbocyclic ring, heterocyclic ring; Z<1> is -COR<1>, -CH=CH-COR<1> etc.; Z<2> is H, alkyl etc.; Z<3> is single bond, alkylene; Z<4> is SO2, CO; Z<5> is alkyl, phenyl, heterocyclic ring etc.; R<2> is CONR<8>, O, S, NZ<6>, Z<7>-alkylene, alkylene etc.; R<3> is H, alkyl, halogen, CF3 etc.; R<4> is H, (substituted) alkyl etc.; n, t is 1-4). The compounds of the formula (I) can bind to receptors of PGE2 and show antagonistic activity against the action thereof or agonistic activity. Therefore, they are considered to be useful as medicine for inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, medicine for increase of vesical capacity or medicine for uterine contraction, cathartic, suppression of gastric acid secretion, antihypertensive or diuretic agents.
Patent AU-5555596-A (AU)
Title: Method for treating dyskinesias
Inventor: BEASLEY CHARLES M JR
IPC: C07D409/04
Filed: 1996-04-18
Abstract: Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thienoÄ2,3-bÜ Ä1,5Ü benzodiazepine, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating a dyskinesia.
Patent AU-5665098-A (AU)
Title: Data transmission method and radio system
Inventor: KOKKONEN MIKKO
IPC: H04J13/00
Filed: 1998-01-15
Abstract: The invention relates to a data transmission method and a radio system comprising at least one base station and a subscriber terminal. In this method each transmitter places reference carriers by an OFDMA moldulator in a band in use substantially randomly, whereby a receiver can use the reference carrier signal for synchronization.
Patent AU-5745598-A (AU)
Title: Joining and connecting component for corrugated pipes
Inventor: SCHWARZ ERNST
IPC: F16L25/00
Filed: 1998-02-11
Abstract: The connecting component or the connecting fitting (1) comprises at least one locking element which can be shifted-in and shifted-out radially to the longitudinal axis (14) of the fitting (1). The locking element is, for example, connected as a wing (7) via a hinge (22) with the fitting (1) or forms an additional element. On the inside face (10) of the locking element (7) are disposed a multiplicity of locking splice-clips (12) which are resilient. When a pipe end is slid into the fitting (1) with the locking elements (7) closed, these locking splice-clips (12) can be deflected. When load is applied against the insertion direction they become clawed in the pipe jacket. This embodiment permits the shifting-in or dosing of the locking elements (7) in a preassembly step and yet ensures a secure connection. The release of the connection through the radial shifting-out of the locking elements (7) is possible at any time.
Patent AU-5764590-A (AU)
Title: Novel propargyl compounds, and uses and processes of preparation thereof
Inventor: HSU CHI-TUNG ADAM
IPC: C07D285/135
Filed: 1990-06-20
Abstract: Compounds of the formula <CHEM>  wherein  Y and Z are each independently O, S, or N-R;  X is H, Br or I; A and R is H, Br or I; are each independently one of; (C1 to C18) straight or branched alkyl; (C3 to C8) cycloalkyl; (C3 to C6) alkenyl; (C3 to C6) alkynyl except propargyl; (C7 to C12) aralkyl; (C6 to C12) aryl optionally substituted with one or more halogen, (C1 to C4) alkyl or haloalkyl, (C1 to C4) alkoxy, nitro, cyano, carboxyl (C1 to C4) alkoxycarbonyl, (C1 to C4) alkyl thio, -S(O)nR<2> where n is 1 or 2 and R2 is (C1-C4) alkyl; a 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 3-pyridyl, or 4-pyridyl moiety each optionally substituted with halo or nitro; or H, with the proviso that R is H only when X is I or Br. are diclosed as useful microbicides and herbicides.
Patent AU-5792694-A (AU)
Title: Filter carrier
Inventor: HANDTMANN THOMAS
IPC: B01D25/26
Filed: 1994-03-22
Abstract: The present invention relates to a filter carrier 1 for the construction of a filter tower 9. To simplify the construction on the whole, the invention provides for a seal which is arranged on the pressure-exerting plate of the filter carrier and comprises a sealing edge for sealing between the pressure-exerting plate and. the side wall of a filter carrier positioned thereunder, as well as a sealing collar for sealing and retaining the distributor element on the pressure-exerting plate.